235 related articles for article (PubMed ID: 1727873)
21. Suppression of follicular trapping of antigen-antibody complexes in mice treated with anti-IgM or anti-IgD antibodies from birth.
Enriquez-Rincon F; Andrew E; Parkhouse RM; Klaus GG
Immunology; 1984 Dec; 53(4):713-9. PubMed ID: 6389323
[TBL] [Abstract][Full Text] [Related]
22. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
[TBL] [Abstract][Full Text] [Related]
23. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
24. Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population.
Metcalf ES; Mond JJ; Finkelman FD
J Immunol; 1983 Aug; 131(2):601-5. PubMed ID: 6602841
[TBL] [Abstract][Full Text] [Related]
25. Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin.
Pezzutto A; Rabinovitch PS; Dörken B; Moldenhauer G; Clark EA
J Immunol; 1988 Mar; 140(6):1791-5. PubMed ID: 3257985
[TBL] [Abstract][Full Text] [Related]
26. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
[TBL] [Abstract][Full Text] [Related]
27. Human tonsil B lymphocyte function. I. The proliferative response to Staphylococcus aureus and pokeweed mitogen in relation to surface heavy chains mu and delta.
Mudde GC; Verberne CJ; Groeneveld K; De Gast GC
Clin Exp Immunol; 1984 Jun; 56(3):709-15. PubMed ID: 6430613
[TBL] [Abstract][Full Text] [Related]
28. Acquisition of surface IgD fails to protect from tolerance-induction. Both surface IgM- and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes.
Norvell A; Monroe JG
J Immunol; 1996 Feb; 156(4):1328-32. PubMed ID: 8568230
[TBL] [Abstract][Full Text] [Related]
29. Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1.
Geisberger R; Königsberger S; Achatz G
Immunol Lett; 2006 Feb; 102(2):169-76. PubMed ID: 16219364
[TBL] [Abstract][Full Text] [Related]
30. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth.
Skelly RR; Baine Y; Ahmed A; Xue B; Thorbecke GJ
J Immunol; 1983 Jan; 130(1):15-8. PubMed ID: 6600173
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
[TBL] [Abstract][Full Text] [Related]
32. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
33. A mitogen for human B cells: anti-Ig coupled to polyacrylamide beads activates blood mononuclear cells independently of T cells.
Fothergill JJ; Wistar R; Woody JN; Parker DC
J Immunol; 1982 May; 128(5):1945-9. PubMed ID: 6977576
[TBL] [Abstract][Full Text] [Related]
34. Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
Kikutani H; Nakamura H; Sato R; Kimura R; Yamasaki K; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4027-34. PubMed ID: 2422270
[TBL] [Abstract][Full Text] [Related]
35. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
Mongini PK; Blessinger C; Posnett DN; Rudich SM
J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
[TBL] [Abstract][Full Text] [Related]
36. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells.
Soulas P; Koenig-Marrony S; Julien S; Knapp AM; Garaud JC; Pasquali JL; Martin T
Eur J Immunol; 2002 Sep; 32(9):2623-34. PubMed ID: 12207347
[TBL] [Abstract][Full Text] [Related]
37. Respiratory burst in human B lymphocytes. Triggering of surface Ig receptors induces modulation of chemiluminescence signal.
Leca G; Benichou G; Bensussan A; Mitenne F; Galanaud P; Vazquez A
J Immunol; 1991 May; 146(10):3542-9. PubMed ID: 1851193
[TBL] [Abstract][Full Text] [Related]
38. Requirements of a costimulus for IL-4-induced IgE class switching in murine B cells activated via antigen receptors: effectiveness of 8-mercaptoguanosine.
Hikida M; Takai T; Ohmori H
J Immunol; 1996 Apr; 156(8):2730-6. PubMed ID: 8609390
[TBL] [Abstract][Full Text] [Related]
39. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
Jelinek DF; Splawski JB; Lipsky PE
J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
[TBL] [Abstract][Full Text] [Related]
40. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
Klaus GG; Bijsterbosch MK; Parkhouse RM
Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
